Get the Stockscreener App
26.35
2.77%
-0.75
After Hours:
26.43
0.08
+0.30%
Doximity Inc stock is traded at $26.35, with a volume of 1.98M.
It is down -2.77% in the last 24 hours and up +20.37% over the past month.
Doximity Inc provides an online platform, which enables physicians and other healthcare professionals to collaborate with colleagues, stay up to date with the latest medical news and research, manage their careers and on-call schedules, streamline documentation and administrative paperwork, and conduct virtual patient visits. The Company's customers include pharmaceutical companies and health systems that connect with healthcare professionals through the Company's digital Marketing, Hiring, and Workflow Solutions. Marketing Solutions provide customers with the ability to share tailored content on the network. Hiring Solutions enable customers to identify, connect with, and hire from the network of both active and passive potential medical professional candidates.
See More
Previous Close:
$27.10
Open:
$26.77
24h Volume:
1.98M
Relative Volume:
0.42
Market Cap:
$4.70B
Revenue:
$644.86M
Net Income/Loss:
$196.05M
P/E Ratio:
26.85
EPS:
0.9812
Net Cash Flow:
$317.50M
1W Performance:
-1.42%
1M Performance:
+20.37%
6M Performance:
-0.34%
1Y Performance:
-61.54%
1-Day Range:
$26.31
$27.03
1-Week Range:
$25.84
$27.32
52-Week Range:
$17.15
$76.51
Doximity Inc Stock (DOCS) Company Profile
Name
Doximity Inc
Sector
Industry
Phone
(650) 549-4330
Address
500 THIRD STREET, SUITE 510, SAN FRANCISCO
Compare DOCS vs VEEV, BTSG, TEM, TXG, HQY
| Stocks | Price | Market Cap | Revenue | Net Income | Cash Flow | EPS |
|---|---|---|---|---|---|---|
DOCS
Doximity Inc
|
26.35 | 4.62B | 644.86M | 196.05M | 317.50M | 0.9812 |
VEEV
Veeva Systems Inc
|
275.09 | 40.70B | 3.32B | 941.65M | 1.64B | 5.6161 |
BTSG
Brightspring Health Services Inc
|
60.73 | 11.78B | 13.65B | 169.86M | 412.12M | 1.0758 |
TEM
Tempus Ai Inc
|
64.62 | 12.03B | 1.36B | -302.91M | -219.93M | -1.7182 |
TXG
10 X Genomics Inc
|
62.65 | 8.32B | 638.78M | -22.66M | 122.18M | -0.1744 |
HQY
Healthequity Inc
|
96.07 | 8.72B | 1.34B | 230.70M | 440.96M | 2.6695 |
Doximity Inc Stock (DOCS) Upgrades & Downgrades
| Date | Action | Analyst | Rating Change |
|---|---|---|---|
| Apr-20-26 | Downgrade | Truist | Buy → Hold |
| Apr-08-26 | Downgrade | Evercore ISI | Outperform → In-line |
| Feb-09-26 | Upgrade | Canaccord Genuity | Hold → Buy |
| Feb-06-26 | Upgrade | JP Morgan | Underweight → Neutral |
| Jan-20-26 | Upgrade | Wells Fargo | Equal Weight → Overweight |
| Jan-09-26 | Initiated | RBC Capital Mkts | Outperform |
| Jan-08-26 | Upgrade | Truist | Hold → Buy |
| Dec-15-25 | Upgrade | Morgan Stanley | Equal-Weight → Overweight |
| Dec-09-25 | Initiated | Barclays | Overweight |
| Nov-21-25 | Upgrade | Raymond James | Outperform → Strong Buy |
| Nov-13-25 | Initiated | BMO Capital Markets | Market Perform |
| Oct-27-25 | Upgrade | BofA Securities | Neutral → Buy |
| Oct-10-25 | Downgrade | JP Morgan | Neutral → Underweight |
| Oct-01-25 | Downgrade | Goldman | Neutral → Sell |
| Jul-09-25 | Upgrade | Evercore ISI | In-line → Outperform |
| Jun-02-25 | Upgrade | BTIG Research | Neutral → Buy |
| Feb-07-25 | Upgrade | Leerink Partners | Market Perform → Outperform |
| Feb-07-25 | Upgrade | Piper Sandler | Neutral → Overweight |
| Dec-20-24 | Initiated | Stephens | Equal-Weight |
| Dec-04-24 | Initiated | Mizuho | Neutral |
| Nov-15-24 | Initiated | Goldman | Neutral |
| Nov-14-24 | Upgrade | Morgan Stanley | Underweight → Equal-Weight |
| Nov-13-24 | Downgrade | Canaccord Genuity | Buy → Hold |
| Nov-08-24 | Upgrade | KeyBanc Capital Markets | Sector Weight → Overweight |
| Nov-08-24 | Upgrade | Wells Fargo | Underweight → Equal Weight |
| Oct-15-24 | Upgrade | Barclays | Equal Weight → Overweight |
| Aug-09-24 | Upgrade | Needham | Hold → Buy |
| Jul-18-24 | Downgrade | Wells Fargo | Equal Weight → Underweight |
| Apr-25-24 | Upgrade | JP Morgan | Underweight → Neutral |
| Feb-26-24 | Initiated | Leerink Partners | Market Perform |
| Jan-03-24 | Initiated | Barclays | Equal Weight |
| Jan-02-24 | Upgrade | BofA Securities | Underperform → Neutral |
| Aug-09-23 | Downgrade | Guggenheim | Buy → Neutral |
| Aug-09-23 | Downgrade | Needham | Buy → Hold |
| Aug-03-23 | Downgrade | Piper Sandler | Overweight → Neutral |
| May-01-23 | Downgrade | Wells Fargo | Overweight → Equal Weight |
| Jan-06-23 | Downgrade | Morgan Stanley | Equal-Weight → Underweight |
| Oct-31-22 | Initiated | Wells Fargo | Overweight |
| Oct-24-22 | Initiated | Evercore ISI | In-line |
| Oct-13-22 | Initiated | BTIG Research | Neutral |
| Sep-16-22 | Initiated | KeyBanc Capital Markets | Sector Weight |
| Sep-07-22 | Initiated | Truist | Hold |
| Aug-05-22 | Downgrade | BofA Securities | Neutral → Underperform |
| Jul-28-22 | Initiated | Berenberg | Buy |
| May-18-22 | Reiterated | BofA Securities | Neutral |
| May-18-22 | Reiterated | Goldman | Buy |
| May-18-22 | Reiterated | Guggenheim | Buy |
| May-18-22 | Reiterated | Jefferies | Buy |
| May-18-22 | Reiterated | Morgan Stanley | Equal-Weight |
| May-18-22 | Reiterated | Needham | Buy |
| Apr-07-22 | Initiated | Guggenheim | Buy |
| Apr-04-22 | Initiated | BofA Securities | Neutral |
| Feb-11-22 | Initiated | Goldman | Buy |
| Dec-14-21 | Downgrade | JP Morgan | Neutral → Underweight |
| Dec-02-21 | Initiated | Jefferies | Buy |
| Nov-17-21 | Initiated | Robert W. Baird | Outperform |
| Nov-10-21 | Reiterated | Canaccord Genuity | Buy |
| Nov-10-21 | Reiterated | Goldman | Neutral |
| Nov-10-21 | Reiterated | Morgan Stanley | Equal-Weight |
| Nov-10-21 | Reiterated | Needham | Buy |
| Nov-10-21 | Reiterated | Piper Sandler | Overweight |
| Aug-26-21 | Downgrade | JP Morgan | Overweight → Neutral |
| Jul-19-21 | Initiated | Canaccord Genuity | Buy |
| Jul-19-21 | Initiated | Goldman | Neutral |
| Jul-19-21 | Initiated | JP Morgan | Overweight |
| Jul-19-21 | Initiated | Morgan Stanley | Equal-Weight |
| Jul-19-21 | Initiated | Piper Sandler | Overweight |
| Jul-19-21 | Initiated | Raymond James | Outperform |
| Jul-19-21 | Initiated | SVB Leerink | Outperform |
| Jul-19-21 | Initiated | William Blair | Outperform |
View All
Doximity Inc Stock (DOCS) Latest News
Doximity (NYSE:DOCS) Given New $27.00 Price Target at Barclays - MarketBeat
A Doximity Director Moved 7,500 Shares the Day the Stock Popped 33%. Here's What to Know - AOL.com
DOXIMITY : BARCLAYS RAISES TARGET PRICE TO $27 FROM $20 - Bitget
Doximity (DOCS) Latest Quarter: Profit Per Share Falls Below Its Benchmark at the Close; Stock Move: The Market Price Moves 3.25% Higher in Latest TradingRevenue Guidance Update - Vinanet
Doximity (DOCS) Latest Quarter: Profit Per Share Falls Below Its Benchmark at the Close; Stock Move - Vinanet
SK Hynix, SpaceX, Doximity, Trade Desk, Rigetti, Coherent, and More Stocks That Explain Today's Market -- Barrons.com - Moomoo
Doximity (DOCS) Results Breakdown: EPS Does Not Reach the Reported Estimate in the Reported Period; Post-Report: Shares Rise 3.25% on the DayEarnings Beat Streak - Vinanet
Doximity (DOCS) Stock Looks Cheap On Cash Flow Yet Fair On Earnings - Yahoo Finance
Doximity (DOCS) Stock Could Be 31% Undervalued Following Raised AI Outlook - simplywall.st
Doximity (DOCS) Q1 2027 Earnings Call Transcript - AOL.com
Doximity (DOCS) Could Be 26% Below Fair Value On Strong Earnings Guidance - Yahoo Finance
Doximity (NYSE:DOCS) Valuation Debate Gets More Interesting - Kalkine Media
What Investors Should Know of This Doximity Officer's Latest Insider Transaction - The Motley Fool
Doximity Handed Its President 150,000 Options Last Month. Here's What the Latest Filing Signals for Investors - The Motley Fool
Doximity's New CFO Just Filed His First Form 4. Here's What Long-Term Investors Should Know. - The Motley Fool
Doximity's Co-Founder Just Filed a Form 4. Is There Anything in It Worth Worrying About? - The Motley Fool
What Investors Should Know of This Doximity Officer's Latest Insider Transaction - The Motley Fool
Is Doximity (DOCS) Turning Rising AI Revenue Into Sustainable Profits Or Margin Trade-Offs? - webull.com
Doximity CAO Siddharth Sitaram sells $44,143 of class A stock By Investing.com - Investing.com South Africa
Doximity CAO Siddharth Sitaram sells $44,143 of class A stock - Investing.com
Doximity (NYSE:DOCS) CAO Siddharth Sitaram Sells 1,770 Shares of Stock - MarketBeat
Doximity, Inc. (DOCS) Stock Analysis: Navigating a 17.38% Potential Upside Amidst Health Information Services Growth - DirectorsTalk Interviews
Bank of America Corp DE Grows Position in Doximity, Inc. $DOCS - MarketBeat
DOCS Stock Soars After CEO Says Clinical AI Outperformed Anthropic, Wall Street Lifts Price Targets - Stocktwits
Rapid7, 8x8, Doximity, Marqeta, and Tenable Shares Are Soaring, What You Need To Know - Yahoo Finance
Doximity Earnings Call Highlights Profitable AI Push - TipRanks
Clinical AI Use Surges as Revenue Climbs & Doctors Embrace New Tools - Streetwise Reports
The 5 Most Interesting Analyst Questions From Doximity’s Q2 Earnings Call - Yahoo Finance
Doximity AI Tools Fuel Physician Engagement Growth Amid Healthcare Digital Shift - Streetwise Reports
DOCS|Doximity Inc|Price:25.298|Chg%:+0.358 - TradingKey
Doximity (NYSE:DOCS) Trading Down 5.6%Here's Why - MarketBeat
Doximity, Inc. (DOCS) Q4 2025 Earnings – Full Coverage Heather Watson (LwrmLN9W8f) - Mshale
Royal Bank of Canada Has $4.81 Million Stock Position in Doximity, Inc. $DOCS - MarketBeat
Doximity Inc (DOCS) Shares Surge 6.4% -- What GF Score of 86 Tel - GuruFocus
Doximity Inc. (DOCS) Q2 2026 Earnings: EPS Misses Consensus While Shares Rise 6.4%Tax Rate Impact - dars.gov.et
Doximity Doubled, Then Gave Most of It Back. Here’s Why the Market Doesn’t Trust the Rally - Yahoo Finance
Doximity, Inc. (DOCS) Stock Forecasts - Yahoo! Finance Canada
Doximity (NYSE: DOCS) insider schedules 1,770-share stock option sale - Stock Titan
Truist Lifts Doximity Target to $24 and Stays on Hold - TradingView
Truist raises Doximity stock price target on updated model By Investing.com - Investing.com Australia
Doximity, Inc. : Truist Securities Raises Tar - Moomoo
Truist raises Doximity stock price target on updated model - Investing.com
Doximity Inc Stock (DOCS) Financials Data
Revenue
Net Income
Cash Flow
EPS
3.87%
1.77%
Open in Yahoo
|
Open in Google
|
Open in Finviz
|
Open in MarketWatch
|
Open in EDGAR
|
Open in Reuters
Cap:
|
Volume (24h):